Clinical remission and control in severe asthma: agreements and disagreements

Annamaria Bosi, Carlo Lombardi, Cristiano Caruso, Marcello Cottini, Ilaria Baglivo, Stefania Colantuono, Francesco Menzella

Article Type

Review

Published

This narrative review aims to frame the evolution of the debated concept of clinical remission as an ambitious and now concretely achievable outcome in modern asthma management, to highlight correct management of inhaled therapies, oral corticosteroids and biological drugs in this context, and, finally, to provide clinicians with insights that could be useful to achieve remission in the greatest possible number of patients.

Read more

Childhood guttate psoriasis: an updated review

Alexander KC Leung, Benjamin Barankin, Joseph M Lam, Kin Fon Leong

Article Type

Review

Published

This review aims to familiarize physicians with the clinical manifestations, evaluation, diagnosis and proper management of guttate psoriasis.

Read more

Considerations for the US health-system pharmacist in a world of biosimilars

Andrea Zlatkus CRHC, Todd Bixby RPh, Kavitha Goyal MD

Article Type

Editorial

Published

This editorial article provides an overview of the evolving healthcare landscape shaped by the entry of multiple biosimilars, including for a given reference product, and their impact on the healthsystem pharmacist with respect to formulary assessment, implementation, and education of various health-system stakeholders, including patients.

Read more

The biosimilars journey: current status and ongoing challenges

Igor Age Kos MD, Valderílio Feijó Azevedo MD, PhD, Daniel Egg Neto, Sérgio Cândido Kowalski MD, PhD

Article Type

Review

Published

Biosimilar products are already approved and marketed in several countries. This review focuses on remaining challenges regarding biosimilars, such as the lack of regulatory harmony, especially concerning naming, the marketed intended copies, the interchangeability, and the biosimilars in orphan diseases.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.